DNM2 and Miyoshi myopathy: In the absence of sEVs, knockdown of DNM2 or CLTC did not induce further changes in the apoptosis of MM cells treat with or without bortezomib (Figure S6B), whereas they significantly decreased the proportion of early apoptotic cells after treatment with bortezomib in the presence of sEVs (Figure 6J-K).